# Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

> **NCT05802173** · PHASE2 · COMPLETED · sponsor: **Technoderma Medicines Inc.** · enrollment: 71 (actual)

## Conditions studied

- Alopecia, Androgenetic

## Interventions

- **DRUG:** TDM-105795, 0.0025%
- **DRUG:** TDM-105795, 0.02%
- **DRUG:** TDM-105795 topical vehicle solution

## Key facts

- **NCT ID:** NCT05802173
- **Lead sponsor:** Technoderma Medicines Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-06
- **Primary completion:** 2023-11-08
- **Final completion:** 2024-01-29
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2025-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05802173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05802173, "Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05802173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*